ENDOMETRIOSIS / UTERINE FIBROID CLINICAL RESEARCH TRIAL
​
Endometriosis is a common yet often debilitating condition that affects millions of women worldwide. Approximately 1 in 10 women suffer from endometriosis, leading to symptoms that can interfere with daily activities, relationships, and overall quality of life. This clinical trial is designed to explore how a promising treatment option can help those living with chronic pain due to endometriosis.
​
By participating, you can help advance medical research and potentially benefit from new treatment options designed to manage pain and improve your quality of life.
​
Endometriosis pain shouldn’t hold you back. BioCentric Health Research Center is conducting an important medical study to test the effectiveness of a promising treatment option that combines Elagolix 150 mg with a low-dose oral contraceptive. If you qualify, this study offers you a unique opportunity to explore potential relief from chronic pain while contributing to meaningful endometriosis research.
About the Study
​
Endometriosis is a common yet often debilitating condition that affects millions of women worldwide. Approximately 1 in 10 women suffer from endometriosis, leading to symptoms that can interfere with daily activities, relationships, and overall quality of life. This clinical trial is designed to explore how a promising treatment option can help those living with chronic pain due to endometriosis. By participating, you can help advance medical research and potentially benefit from new treatment options designed o manage pain and improve your quality of life.
​
​
Eligibility Criteria
You may qualify to participate if you:
-
Are between 18-49 years old and experience endometriosis pain.
-
Have a documented diagnosis of endometriosis.
-
Are open to using non-hormonal birth control during the study.
Participants may receive up to $2,000 in compensation for time and travel related to the study.
What to Expect
​
As a participant, you’ll be closely monitored by our experienced healthcare team. This includes regular check-ins, easy access to study information, and personalized support to ensure your comfort throughout the study experience. Join a community committed to women’s health and endometriosis research. BioCentric’s compassionate, knowledgeable team will be with you every step of the way, ensuring you have the information and support you need.
​
​
​How to Get Started
Ready to make a difference and explore potential relief? Here’s how to connect:
-
Fill out our interest form below – a quick way to see if this study is right for you.
-
Contact Haylee Kasuboski, our Patient Recruitment Specialist, by email at hkasuboski@biohrc.com or call toll-free at 803.764.2406.
​
Join Us in Finding a Path Forward for Endometriosis Relief
Don't wait—take the first step toward pain relief and help make a difference for others with endometriosis. Sign up below or reach out to us directly to discuss the study details and your potential involvement.
​
Did you know?
-
1 in 10 women suffer from endometriosis, with 6 million women in the U.S. alone affected by this chronic, often debilitating condition.
-
90% of women with endometriosis experience chronic pelvic pain, impacting their daily lives, work, and relationships.
-
It can take an average of 7-10 years to receive a correct diagnosis, which delays much-needed treatment and relief.
-
Endometriosis is one of the leading causes of infertility, affecting up to 50% of women who are trying to conceive.
​
Your participation matters. Join our clinical trial to help advance research and explore a promising new treatment option for managing endometriosis pain. By participating, you could contribute to groundbreaking advancements and potentially find the relief you’ve been searching for.
BioCentric Health Research Center: Leading the Way in Clinical Trials for Women’s Health
At BioCentric Health Research Center, we are committed to advancing medical knowledge and providing cutting-edge research opportunities for patients. With our experienced team of healthcare professionals and state-of-the-art research facility, we’ve been at the forefront of clinical trials since 2013. Our patient-centered approach ensures that your health and well-being are always our top priority.
Join us in our mission to improve treatments for women’s health and make a lasting impact on the future of medical care.
When asked to do the study, I was worried it wouldn't work, but it was amazing. The people who work on the study were amazing also, and they made it so easy to understand. They made me feel like family when I was there. I would tell anybody who has Endometriosis that the study is so worth it because I could live my life with no pain.
— Tracy, Enrolled Patient
Did you know?
-
1 in 10 women suffer from endometriosis, with 6 million women in the U.S. alone affected by this chronic, often debilitating condition.
-
90% of women with endometriosis experience chronic pelvic pain, impacting their daily lives, work, and relationships.
-
It can take an average of 7-10 years to receive a correct diagnosis, which delays much-needed treatment and relief.
-
Endometriosis is one of the leading causes of infertility, affecting up to 50% of women who are trying to conceive.
Your participation matters. Join our clinical trial to help advance research and explore a promising new treatment option for managing endometriosis pain. By participating, you could contribute to groundbreaking advancements and potentially find the relief you’ve been searching for.
BioCentric Health Research Center: Leading the Way in Clinical Trials for Women’s Health
At BioCentric Health Research Center, we are committed to advancing medical knowledge and providing cutting-edge research opportunities for patients. With our experienced team of healthcare professionals and state-of-the-art research facility, we’ve been at the forefront of clinical trials since 2013. Our patient-centered approach ensures that your health and well-being are always our top priority.
​
Join us in our mission to improve treatments for women’s health and make a lasting impact on the future of medical care.